What medicine does centrality chondrosarcoma take

summary

Chondrosarcoma refers to the tendency of chondrogenic differentiation, which is divided into central chondrosarcoma, peripheral chondrosarcoma and periosteal chondrosarcoma. Chondrosarcoma grows slowly. The disease occurs in the proximal femur, pelvis, humerus, scapula and tibia. The clinical symptoms are deep pain, not severe, non persistent, nerve compression, causing severe pain, accompanied by radiation pain. Surgical resection is the main treatment with high cure rate. Local recurrence and metastasis can still occur more than 10 years after primary tumor resection. Radiotherapy and chemotherapy have no effect on the disease. So what medicine does centrality chondrosarcoma take

What medicine does centrality chondrosarcoma take

The treatment of central chondrosarcoma is surgical resection. At the time of initial diagnosis, most of the central chondrosarcomas had no lung metastasis. Surgical resection had a high cure rate, and limb salvage therapy was used.

Curettage is not appropriate regardless of the histological grade of central chondrosarcoma. Intralesional resection is only suitable for the borderline cases between chondroma and grade I central chondrosarcoma, which may be cured. However, this kind of intralesional resection should be extensive, and local adjuvants such as carbolic acid, bone cement and liquid nitrogen should be used.

The resection margin of central chondrosarcoma must reach extensive or radical resection. After marginal resection, the risk of tumor recurrence is high, which increases with the increase of histological malignancy. In most cases, extensive resection can achieve limb salvage.

matters needing attention

Amputation is suitable for central chondrosarcoma with huge soft tissue tumor, especially in grade III central chondrosarcoma and dedifferentiated chondrosarcoma.